Search Orphan Drug Designations and Approvals
-
Generic Name: | leriglitazone |
---|---|
Date Designated: | 08/01/2019 |
Orphan Designation: | Treatment of Friedreich´s ataxia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Minoryx Therapeutics S.L. TecnoCampus Mataro-Maresme. TCM3 602 Av. Ernest Lluch, 32. Mataró, Catalunya Spain The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-